Many studies show that, Spirulina demonstrates antiviral, immunomodulatory and anti-inflammatory properties. These properties are attributable to the Spirulina phycobiliprotein-phycocyanin complex.
The anti-inflammatory, antiviral properties, and safety of Spirulina and phycocyanin-rich Spirulina extracts are well documented.
Phycocyanin has been shown to safe for human consumption and there are no apparent side effect and drug interaction issues. Natural phycocyanin-rich Spirulina extracts should be tested in COVID-19, especially in the mitigation of cytokine release syndrome.
Spirulina, has been used for millennia as a plant-based remedy and health food, should hold the key to fight the diseases of the modern society.
DQS team is working hard to bring the fresh Spirulina products to the community. We hope to contribute our small part in making a healthier society.
Source article: BYAS-Natural Product Therapeutics and COVID-19: The Case for Clinical Development of Spirulina Extracts